EVOKE PHARMA INC (EVOK)
US30049G2030 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.74M | 9.84M | 9.14M | 8.07M | 5.66M | |||
| Receivables | 673.07K | 620.00K | 300.00K | 20.00K | N/A | |||
| Inventories | 481.84K | 290.00K | 190.00K | 240.00K | N/A | |||
| Other Current Assets | 932.57K | 960.00K | 930.00K | 950.00K | 580.00K | |||
| Total Current Assets | 6.83M | 11.72M | 10.56M | 9.28M | 6.25M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 130.00K | 10.00K | 140.00K | 140.00K | |||
| Other Non-Current Assets | 241.64K | N/A | 0.00 | 10.00K | 10.00K | |||
| Total Non-Current Assets | 241.64K | 130.00K | 10.00K | 150.00K | 150.00K | |||
| TOTAL ASSETS | 7.07M | 11.85M | 10.57M | 9.43M | 6.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 100.00K | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 1.32M | 720.00K | 530.00K | 1.16M | 980.00K | |||
| Accounts Payable | 1.71M | 930.00K | 870.00K | 1.27M | 1.03M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 5.00M | N/A | |||
| Total Current Liabilities | 3.04M | 1.65M | 1.41M | 7.54M | 2.02M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 5.00M | 5.00M | 5.00M | 5.00M | 0.00 | |||
| Other Non-Current Liabilities | 1.61M | 1.11M | 610.00K | 110.00K | N/A | |||
| Total Non-Current Liabilities | 6.61M | 6.12M | 5.61M | 5.11M | 0.00 | |||
| TOTAL LIABILITIES | 9.65M | 7.77M | 7.02M | 12.65M | 2.02M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -123.44M | -115.65M | -107.42M | -98.89M | -85.73M | |||
| Additional Paid In Capital | 120.86M | 119.73M | 110.97M | 95.67M | 90.11M | |||
| Common Shares | 330.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 3.34M | 3.34M | 2.72M | 2.22M | 2.04M | |||
| Tangible Book Value per Share | -0.77 | 1.22 | 1.31 | -1.45 | 2.15 | |||
| Total Shareholders' Equity | -2.58M | 4.08M | 3.56M | -3.21M | 4.38M | |||
| TOTAL LIABILITIES AND EQUITY | 7.07M | 11.85M | 10.57M | 9.43M | 6.40M | |||
| Statistics | ||||||||
| Debt/Equity | -1.94 | 1.23 | 1.40 | -1.59 | N/A | |||
| Current Ratio | 2.25 | 7.10 | 7.49 | 1.23 | 3.09 | |||
| Return On Assets (ROA) | -110.24% | -69.37% | -80.79% | -139.45% | -111.41% | |||
| Return On Equity (ROE) | N/A | -201.47% | -239.89% | N/A | -162.79% | |||
All data in USD